comunicacio

Absolute success of the Sinergia 2023 open day

Leave a Comment / Outreach and education / By

This Saturday took place the open day of the fifth edition of Sinergia, the celebration of health research and innovation in L’Hospitalet. More than 300 people came to the Bellvitge Campus to take part in the everyday work of that IDIBELL, the Catalan Institute of Oncology, the Bellvitge University Hospital, the University of Barcelona and the Hospital Sant Joan de Déu do to improve people’s health.

Absolute success of the Sinergia 2023 open day Read More »

The Mediterranean diet and olive oil may benefit the prevention of some types of cancers related to obesity

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Nutrition and Cancer / By

A new study carried out by the Nutrition and Cancer research group of IDIBELL and the Catalan Institute of Oncology, with the collaboration of the scientific and technological center AZTI, offers a relevant review and update of data that demonstrates how eating habits and the microbiota intestine could play a key role in cancer prevention.

The Mediterranean diet and olive oil may benefit the prevention of some types of cancers related to obesity Read More »

A new treatment to prevent infections acquired in the Intensive Care Unit (ICU) discovered by researchers from IDIBELL and the Bellvitge University Hospital enters the Clinical Phase

Leave a Comment / Sin categorizar / By

The new treatment is a drug that eliminates the antibodies that bind to gram-negative bacteria and makes them resistant to destruction by the immune system.

A new treatment to prevent infections acquired in the Intensive Care Unit (ICU) discovered by researchers from IDIBELL and the Bellvitge University Hospital enters the Clinical Phase Read More »

Researchers at CNIO and IDIBELL shed light on the role in lactation of a protein also crucial in breast cancer

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Transformation and Metastasis / By

When the RANK protein was suppressed in luminal cells of the breast tissue in female mice, they did not produce milk in their first pregnancy.

Researchers at CNIO and IDIBELL shed light on the role in lactation of a protein also crucial in breast cancer Read More »

The IDIBELL’s spin-off ADmit therapeutics closes a €5.4 million funding round

Leave a Comment / Sin categorizar / By

ADmit Therapeutics is a biotechnology company founded at the end of 2017 as a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL). The company is focused on the development and commercialization of a new early detection technology for Alzheimer’s disease (AD) and has successfully closed a €5.4 million equity round.

The IDIBELL’s spin-off ADmit therapeutics closes a €5.4 million funding round Read More »

Research led in Bellvitge will allow progress in the fight against bacteremia

Leave a Comment / Difficult to Treat Infections and Antimicrobians Use , Infectious disease and transplantation Program, Translational Medicine Area / By

The study has been published in the journal Nature Medicine, one of the most prestigious in Medicine, and represents a step forward to address an important health challenge worldwide, with high rates of therapeutic failure and mortality.

Research led in Bellvitge will allow progress in the fight against bacteremia Read More »

Molecular tests allow more effective detection of endometrial cancer and avoid unnecessary hysterectomies in women with postmenopausal bleeding

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Infections and Cancer / By

The study performs an evaluation to determine the cost-effectiveness and profitability of two strategies for the early detection of endometrial cancer in women with postmenopausal bleeding.

Molecular tests allow more effective detection of endometrial cancer and avoid unnecessary hysterectomies in women with postmenopausal bleeding Read More »

One in three men worldwide are infected with genital human papillomavirus

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Infections and Cancer / By

1 in 3 men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and 1 in 5 are infected with one or more of what are known as high risk, or oncogenic, HPV types

One in three men worldwide are infected with genital human papillomavirus Read More »

A new clinical algorithm increases the diagnosis rate of rare diseases

Leave a Comment / Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

A research team led by Aurora Pujol and Dr. Carlos Casasnovas developed an innovative computational algorithm called ClinPrior. This algorithm demonstrated its ability to improve the diagnosis rate in patients with rare diseases of genetic origin.

A new clinical algorithm increases the diagnosis rate of rare diseases Read More »

Scroll to Top